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Regulation of cell cycle progression occurs in part through the targeted degradation of both activating and
inhibitory subunits of the cyclin-dependent kinases. During G1, CDC4, encoding a WD-40 repeat protein, and
CDC34, encoding a ubiquitin-conjugating enzyme, are involved in the destruction of these regulators. Here we
describe evidence indicating that CDC53 also is involved in this process. Mutations in CDC53 cause a pheno-
type indistinguishable from those of cdc4 and cdc34mutations, numerous genetic interactions are seen between
these genes, and the encoded proteins are found physically associated in vivo. Cdc53p defines a large family of
proteins found in yeasts, nematodes, and humans whose molecular functions are uncharacterized. These re-
sults suggest a role for this family of proteins in regulating cell cycle proliferation through protein degradation.
Progression through the cell cycle in the yeast Saccharomy-
ces cerevisiae requires the activity of a protein kinase whose
catalytic subunit, p34, is encoded by the CDC28 gene (for a
review, see reference 36). The Cdc28p protein kinase is a
member of a large family of highly related protein kinases
known as cyclin-dependent kinases, and the specific role of this
protein kinase at each discrete stage of the cell cycle is defined
by the cyclin subunit with which it is associated. Accordingly,
important regulation of cell cycle progression depends on the
accumulation and degradation of different cyclins during the
different phases of the cell cycle (for a review, see reference
36). Late in the G1 phase, Cdc28p is found complexed with the
G1 cyclins Cln1p, Cln2p, and Cln3p (9, 46, 50), and this activity
is required for executing Start. Activation of Start is marked by
the initiation of several events: spindle pole body (SPB) dupli-
cation, bud emergence, and activation of SBF- and MBF-de-
pendent transcription (5, 24, 35). At the same time, or closely
thereafter, Cdc28p becomes associated with the Clb5p and
Clb6p cyclins. Clb5p and Clb6p, although not required for
viability, are necessary for the timely initiation of DNA repli-
cation (10, 42).
The activity associated with Cdc28p at the various steps in
the cell cycle is also modulated by inhibitory proteins that bind
to specific cyclin-kinase complexes (for reviews, see references
43 and 44). The activities of such inhibitory proteins are them-
selves controlled through degradation (32, 41). For example,
prior to S phase, Clb5p-Clb6p kinase complexes are prevented
from functioning by being bound to the inhibitory Sic1 protein
(41). At the initiation of S phase, these complexes undergo
activation by the degradation of Sic1, leading to DNA replica-
tion (41). If the degradation of Sic1p is prevented, entry into S
phase is blocked and cells remain at the G1-to-S-phase bound-
ary (41).
CDC34 is also critical for the progression of yeast cells into
S phase (12). In the absence of CDC34 function, cells perform
Start-related events but fail to perform subsequent events such
as the replication of nuclear DNA, spindle formation, and
cytokinesis (5, 6). The CDC4 gene product has also been
shown to be required for these events (5, 14). In fact, cells
mutant for cdc4 or cdc34 are thus far phenotypically indistin-
guishable from one another.
Both CDC4 and CDC34 have been characterized at the
molecular level (12, 52). CDC4 encodes a protein containing
WD-40 repeats, the specific role of which in cell cycle control
remains undefined. CDC34 encodes a ubiquitin-conjugating
enzyme that catalyzes the formation of a polyubiquitin chain
on several substrate proteins (3, 8, 12). The presence of poly-
ubiquitin as a posttranslational modification serves in targeting
proteins for degradation by the ATP-dependent protease
called the proteasome (for a review, see reference 16). Cdc34p,
as well as Cdc4p, has been shown to be involved in the de-
struction of multiple cell cycle regulators, including Cln2p,
Cln3p, Far1p, and Sic1p (8, 26, 30, 41, 47, 51). Furthermore, in
the absence of Cdc34p or Cdc4p activity, the Cln kinase com-
plexes required for Start remain active (47), but the Clb5p-6p
kinase complexes that are required for the initiation of S phase
are not activated (41).
Although the evidence suggesting that the Cdc34p-mediated
destruction of both the cyclins and inhibitory proteins is a key
regulatory event of the G1-to-S-phase transition is compelling,
the mechanisms by which the activity of Cdc34p is controlled
and by which it recognizes its substrates have remained ob-
scure. We describe here the identification of a gene, CDC53,
that is required at the same stage of the cell cycle as CDC34,
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and we present evidence that Cdc34p acts in concert with
Cdc4p and Cdc53p to execute its cell cycle function. Further-
more, the identification of genes encoding a large family of
Cdc53p-related proteins in higher organisms suggests that the
control of cell cycle progression in higher cells utilizes similar
mechanisms and that these Cdc53p-like proteins also mediate
ubiquitin-dependent protein degradation.
MATERIALS AND METHODS
Yeast strains and media.Yeast strains used in this study are described in Table
1. Strains were grown by using standard media and conditions (13, 37) at the
indicated temperatures. Yeast transformations and genetic manipulations used
standard protocols (37). Yeast mutant collections and genetic screening strate-
gies have been described elsewhere (1, 20, 49).
Flow cytometry and microscopy techniques. Yeast cells were grown under
standard conditions at 238C overnight to a density of 53 106/ml and then shifted
to 368C for 3 h. Cells were then prepared for flow cytometry or electron micros-
copy as described previously (49). For differential interference contrast and
fluorescence microscopy, cells were fixed, stained with propidium iodide as
described for flow cytometry, and visualized in a Nikon FXA microscope as
described previously (11). Images were recorded by using a Pulnix TM-745
camera and an Apple Macintosh Quadra 700 personal computer. Images were
analyzed by using the NIH Image 1.53b2 software.
Plasmids. Plasmid manipulations used standard protocols (38). E3a was re-
covered as a plasmid that could complement the temperature sensitivity of
cdc53-1. Plasmid E3a contains an 8.2-kb DNA fragment isolated from a plasmid
library of Sau3AI-partial-digestion fragments cloned into YEp24 (7). Plasmids
pGEM53-8 and pGEM53-9 contain a 3.6-kb EcoRI DNA fragment encompass-
ing the CDC53 gene ligated into the EcoRI site of pGEM-3 (Promega Corp.) in
the two possible orientations. Plasmid pCDC53-9 contains a 7.0-kb SphI DNA
fragment from E3a cloned into the SphI site of YRp7, and plasmid pCDC53-11
contains a 3.3-kb ApaI-SphI DNA fragment from E3a cloned into the SalI-SphI
sites of YRp7 (45). Plasmid pGEM53-DBglII::HIS3 was constructed by digesting
plasmid pGEM53-8 with BglII and ligating it to a HIS3-containing 1.7-kb BamHI
DNA fragment from CMp170 as described previously (12). This construction
replaces 1.6-kb of the CDC53 coding sequence with the HIS3 gene.
Plasmids pFUS34, pYL150, pSJ101, and pSJ4101 have been described previ-
ously (11, 21, 28). In pFUS34 and pSJ4101, CDC34 and CDC4, respectively, can
be expressed from their native promoters or from the GAL10 promoter. In
pYL150, the native promoter of CDC34 is missing. The 2.6-kb ApaLI-ClaI DNA
fragment from pGEM53-8 was ligated into the SalI-XhoI sites of pSJ101 or the
EcoRI site of pYcDE-2 (kindly provided by B. D. Hall, University of Washing-
ton) (after filling in) to create pFUS53-3 and pYcDE-53, respectively. Plasmid
pFUS53-3 allows CDC53 to be expressed from its own promoter or the GAL10
promoter, whereas pYcDE53-1 has CDC53 expressed from the ADH1 promoter.
The 1.1-kb HindIII DNA fragment of pK34-1 (12) was filled in by Klenow
fragment and ligated into the filled-in SmaI-PvuII fragment of YEp24 to gener-
ate YEp34-1. Plasmid pCDC53-20 was constructed by deleting a 250-bp KpnI
DNA fragment from the coding region of CDC53 within E3a. This plasmid now
encodes a nonfunctional mutant Cdc53p lacking amino acid residues 582 to 665.
To construct pNM53, an SphI-HindIII DNA fragment from plasmid pYcDE-
53 containing the ADH1 promoter and a portion of CDC53 was ligated into the
SphI-HindIII sites of pGEM-7 (Promega Corp.) to create plasmid pNM53D. An
ApaI-NcoI DNA fragment which contains the ADH1 promoter and a portion of
CDC53 was excised from plasmid pNM53D and ligated into the ApaI-NcoI sites
of pMT711 (kindly provided by M. Tyers), to create pNM53. Plasmid pNM53
contains the full-length CDC53 gene under the control of the ADH1 promoter.
Plasmid YEpGALHis34 was constructed as follows. An NdeI-BglII DNA frag-
ment from plasmid pMT729 (kindly provided by M. Tyers) containing the
CDC34 coding region was ligated into the NdeI-BamHI sites of pET15b (No-
vagene). This plasmid is called pHis34 and contains a fusion gene encoding a
Cdc34p with six histidine residues at the N terminus of the protein. A KpnI-
BamHI DNA fragment containing the GAL10 promoter region from plasmid
pSJ101 was ligated into the KpnI-BamHI sites of pGEM3 (Promega Corp.) to
generate pGEM-GAL10. An NcoI-HindIII DNA fragment encoding the His-
tagged Cdc34p from plasmid pHis34 was then ligated into the NcoI-HindIII sites
of plasmid pGEM-GAL10 to generate pGEM-GALHis34. Plasmid pRSGAL-
His34 was generated by ligating a KpnI-HindIII DNA fragment containing the
GAL-His-CDC34 region of plasmid pGEM-GALHis34 into the KpnI-HindIII
sites of pRS316. Finally, YEpGALHis34 was constructed by replacing a ScaI
DNA fragment containing centromere sequences from pRSGALHis34 with the
ScaI DNA fragment containing the 2mm plasmid replication origin from YEp24.
DNA sequencing. The DNA sequence of the CDC53 gene was determined as
described previously (12). Two series of overlapping deletions extending into
either side of CDC53 were generated by exonuclease III digestion (15) using
pGEM53-8 and pGEM53-9 as templates, and the DNA sequence analysis was
performed with Sequenase (U.S. Biochemical) as instructed by the manufac-
turer.
Antibody generation and Western blot (immunoblot) analysis. Anti-Cdc4 and
anti-Cdc53 antisera were prepared in New Zealand White rabbits, using Cdc4p
and Cdc53p immunogens produced in Escherichia coli as described previously
(11). First, plasmid pATH4-5 was created by ligating an 800-bp EcoRV DNA
fragment from pCDC4-35 (52) into the SmaI site of pATH1 (25). Plasmid
pATH53-2 was created by ligating the 1.0-kb XbaI-HindIII DNA fragment from
pGEM53-8 into the XbaI-HindIII sites of pATH2 (25). When pATH4-5 and
pATH53-2 were transformed into E. coli DH-1 and RR1 (38), respectively, the
encoded regions of Cdc4p and Cdc53p were produced as fusions to bacterial
TrpE as described previously (11). These fusion proteins were purified and
injected into rabbits to produce antisera to Cdc4p and Cdc53p. Antibodies to
Cdc4p and Cdc53p were affinity purified prior to Western analysis as described
previously (11).
Yeast cell lysates were prepared and Western analysis was performed as
described previously (11) except that during the electrophoretic transfer of
proteins from the sodium dodecyl sulfate (SDS)-polyacrylamide gel onto poly-
vinylidene fluoride membranes, 10 mM Tris-HCl (pH 7.0) was replaced with 10
mM 3-[cyclohexylamino]-1-propanesulfonic acid (pH 11.0). Affinity-purified an-
ti-Cdc4, anti-Cdc34 (11), and anti-Cdc53 were used at a final concentration of
1/1,000, and the antibodies were visualized by enhanced chemiluminescence
(Amersham) as instructed by the manufacturer.
Purification of His-tagged Cdc34p by nickel chromatography. Yeast cell ly-
sates were prepared as described above except that the cells were lysed in 50 mM
NaCl–50 mM Tris-HCl (pH 7.5)–0.5 mM EDTA–1% Triton. Lysate containing
10 mg of protein was incubated for 5 min with 200 ml of Ni21-nitrilotriacetic acid
agarose beads (Qiagen) that had been previously equilibrated with 50 mM
NaCl–50 mM Tris-HCl (pH 7.5)–30 mM imidazole. The beads were then washed
repeatedly with 2 ml of equilibration buffer containing 30 mM imidazole. The
TABLE 1. Yeast strains used in this study
Strain Genotype Source orreference
5566-1-1 MATa cdc39-1 trp1 lys2 ade2 his4 cry1 SUP4 L. Hartwell
5579-5-2 MATa cdc36-16 trp1 lys2 ade2 his4 cry1 SUP4 L. Hartwell
6353-4-1 MATa cdc4-1 trp1 lys2 ade2 his4 cry1 tyr1
SUP4
L. Hartwell
6353-14-3 MATa cdc4-1 trp1 lys2 ade2 his4 cry1 SUP4 L. Hartwell
7414-2-3 MATa cdc28-1 leu2-3,112 ura3-52 J. Konopka
H122-12-3 MATa cdc10-1 ura1 ade1 ade2 L. Hartwell
H2C2A1 MATa cdc2-2 his7 ura1 L. Hartwell
H3C1B5 MATa cdc3-1 his7 ura1 L. Hartwell
JPT175 MATa cdc53-1 This study
JPTA1528 MATa cdc53-4 This study
JPTA1529 MATa cdc53-3 This study
KJB1 MATa ade2 trp1 ura3-52 mip1::URA3
cdc53-2
This study
MG-F MATa cdc53-1 trp1 This study
MGG3 MATa ura3-52 leu2-3,112 his3 can1 T. Petes
MATa ura3-52 leu2-3,112 his3 can1
MGG10 MATa cdc53-1 ura3-52 trp1 ade2 This study
MGG11 MATa cdc34-1 ura3-52 his3 This study
MGG12 MATa cdc53-1 trp1 his3 ade2 ura3-52 This study
MGG15 MATa cdc34-1 ura3-52 his3 28
MGG47 MG-F 3 YPH52 This study
MGG48 YPH52 3 YPH54 This study
SJ1012-4 MATa cdc4-5 leu2-3,112 ura3-52 lys2
ade1 his7
21
SJ1026-7B MATa cdc4-3 leu2-3,112 ura1 trp1 lys2 his7 21
SJ1026-1B MATa cdc4-3 leu2-3,112 ura1 trp1 lys2 his7 21
SJ1078-2B MATa cdc4-3 leu2-3,112 ura3-52 trp1 lys5
ade2 ade6
21
SJ1080-4D MATa cdc53-1 leu2-3,112 ura3-52 ade2 his7 21
SJ1080-6C MATa cdc53-1 leu2-3,112 ura3-52 ade2 21
SJ1080-8C MATa cdc53-1 leu2-3,112 ura3-52 his7 21
SJ1098-3D MATa cdc34-2 leu2-3,112 ura3-52 trp1 21
ts328 MATa ade1 ade2 ura1 tyr1 lys2 his7 gal1
mnn1 cdc53-2
This study
WX70.3c MATa ade2 cdc53-2 This study
Y382 MATa ade2 ade3 ura3 leu2 trp1 A. Bender
YL10-1 MATa cdc34-2 ura3-52 leu2D-63 his3D 28
YPH52 MATa ura3-52 lys2-801 ade2-101 trp1
his3-200
P. Hieter
YPH54 MATa ura3-52 lys2-801 ade2-101 trp1
his3-200
P. Hieter
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protein bound to the beads was then subjected to Western analysis as described
previously (11).
Nucleotide sequence accession number. The sequence of CDC53 has been
assigned GenBank accession number U43564.
RESULTS
Isolation and characterization of cdc53 mutants. The pres-
ence of multiple, elongated buds at 368C is a characteristic
of cells that contain a temperature-sensitive mutation in ei-
ther CDC4 or CDC34 (5, 6, 14). Therefore, to identify other
genes involved in the same process(es), we screened a col-
lection of Ts2 mutants (1) microscopically for those that
formed abnormal cell shapes under nonpermissive conditions
(growth at 368C). Three mutants, called JPT175, JPTA1528,
and JPTA1529, formed multiple, elongated buds (Fig. 1A).
Backcrosses revealed a single temperature-sensitive mutation
in each strain, and these mutations fell into a single comple-
mentation group differing from all previously characterized cdc
mutations. This complementation group was termed CDC53,
and the alleles found in JPT175, JPTA1529, and JPTA1528
were designated cdc53-1, cdc53-3, and cdc53-4, respectively.
Staining of nuclear DNA in the arrested cells indicated the
presence of a single nucleus (data not shown, but see Fig. 1B
and C). These features of the terminal phenotype were indis-
tinguishable from those of mutants defective for CDC4 or
CDC34 (5, 6, 14). However, the cdc53-1 mutation was geneti-
cally mapped to a position about 24 centimorgans distal to cdc2
on the left arm of chromosome IV (31), which differs from the
map positions of cdc4 and cdc34.
Independent of the above analysis, a second collection of
Ts2 mutants was screened for defects in microtubule organi-
zation (49). The mutation found in strain ts328, when passed
through backcrosses, failed to maintain the original defect in
microtubule organization but caused cells to arrest with a sin-
gle nucleus and multiple, elongated buds (Fig. 1B and C).
Complementation analysis indicated that this mutation (desig-
nated cdc53-2) was allelic with cdc53-1. Further analysis of this
mutant collection also revealed temperature-sensitive muta-
tions with similar phenotypes that failed to complement
cdc34-2. Two of these strains were found to contain previously
unknown alleles of CDC34 that were designated cdc34-4 and
cdc34-5 (28).
More detailed characterization of cells arrested by cdc53
mutation revealed additional similarities to the phenotypes of
cdc4 and cdc34 mutants. Two key features of the arrest seen in
cdc4 and cdc34mutants are the failure to separate the SPBs (5,
6) and to initiate nuclear DNA replication (14). The behavior
of the SPBs in the cdc53 mutants was examined by electron
microscopy. Examination of serial sections through 20 cells of
a cdc53-2 strain arrested for 3 h at 368C revealed in every case
that the SPB had undergone duplication but that the two SPBs
remained in a side-by-side configuration, failing to separate
from one another and form a spindle (Fig. 1D). Cells that
contained the cdc53-1mutation, on the other hand, arrested as
a mixed population containing cells with unseparated SPBs
together with cells that had formed mitotic spindles when in-
cubated under nonpermissive conditions. However, cells con-
taining cdc53-1 arrest with multiple, elongated buds indistin-
guishable from those of cdc53-2 mutants. These results suggest
that the cdc53-1 allele causes a leaky cell cycle arrest rather
than causing cells to arrest at a different stage of the cell cycle.
We performed flow cytometry to determine the nuclear
DNA content of cdc53 mutants under nonpermissive condi-
tions. Within 3 h of shift to 368C, the cdc53-2 mutant arrested
with a G1 DNA content (Fig. 1E). The fact that cells from the
initial S and G2/M peaks were chased into the G1 peak during
incubation at 368C indicates that cells deficient in CDC53 func-
tion can complete nuclear DNA replication and mitosis but are
unable to initiate a new round of DNA replication. Thus, in
each respect analyzed, the cdc53 defects are indistinguishable
from those caused by cdc4 and cdc34.
Synthetic lethal interactions between cdc4, cdc34, and cdc53.
Functional interactions between gene products can sometimes
be detected by synthetic lethality, in which a combination of
alleles that are independently nonlethal cause lethality under
the same conditions (17). To determine whether synthetic le-
thal interactions occur between cdc4, cdc34, and cdc53, strains
containing these mutations were crossed to each other, and the
FIG. 1. Phenotypes of cdc53 mutants. Cells were grown in YM-1 medium overnight at 238C to a density of 106/ml and then shifted to 368C for 3 h or as noted. (A)
Terminal morphology of cdc53-1 strain JPT175. Cells were shifted to 368C for 6 h, stained with Calcofluor as described previously (34), and visualized by fluorescence
microscopy using the UV filter set. (B and C) Cells of strain KJB1 were fixed in ethanol and stained with propidium iodide. Cells were then visualized by differential
interference contrast microscopy (B) or fluorescence microscopy with appropriate filters (C). (D) Cells of cdc53-2 strain WX70.3c have duplicated but unseparated SPBs
in their nuclear envelopes at arrest, as shown by serial thin-section electron microscopy. The pair of SPBs shown lie opposite the darkly stained nucleolus. Scale bar,
0.5 mm. (E) Cells of cdc53-2 strain KJB1 arrest with a G1 content of DNA. Cells were removed at hourly intervals after a shift to 368C, fixed in ethanol, stained with
propidium iodide, and subjected to flow cytometry with a FACScan analyzer.
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resulting diploids were sporulated to test for viability of the
spores at 238C, a permissive temperature for these mutations
(Table 2). Although the viability of spores containing any one
of these temperature-sensitive alleles alone was over 90%, no
spore containing any pair of mutant alleles among these three
genes was ever recovered. Furthermore, when the inviable
spores predicted to contain two mutations were examined mi-
croscopically, most of the dead spores had germinated and
developed multiple, elongated buds typical of strains mutant
for any one of these genes after transfer to nonpermissive
temperature. In contrast, double-mutant combinations were
viable from crosses between mutants for any one of these three
genes (cdc4, cdc34, and cdc53) and a number of other temper-
ature-sensitive cell cycle mutants (Table 2). Liang et al. (27)
have also shown that synthetic lethality is not observed in
crosses between cdc34 and other genes required for the initi-
ation of DNA replication, including cdc6, orc2, and orc5.
Molecular characterization of CDC53. The wild-type CDC53
gene was cloned by complementation of the temperature sen-
sitivity caused by cdc53-3. After transformation with a YEp24-
based yeast genomic library (7), one transformant that grew at
368C was recovered. Plasmid E3a, containing an 8.2-kb insert,
was isolated from this transformant; complementation analysis
using various subcloned fragments demonstrated that the
cdc53-complementing ability of E3a could be localized to a
3.6-kb EcoRI fragment (Fig. 2).
To demonstrate that the complementing plasmids contained
CDC53 rather than a high-copy-number suppressor, the dip-
loid MGG47 (heterozygous for cdc53-1) was transformed with
DNA from plasmid pCDC53-9 (see Materials and Methods)
after digestion with ApaI to target integration to the CDC53
locus. Two transformants, MGG47-1 and MGG47-2, which
should contain a tandem duplication of CDC53 and a copy of
TRP1 at the CDC53 locus, were sporulated and subjected to
tetrad analysis. The integrated plasmid sequences in these two
strains segregated away from the cdc53-1 allele in 11 of 11 and
9 of 9 tetrads, respectively, demonstrating that the plasmid
sequences had indeed integrated at a genomic location tightly
linked to cdc53-1. Southern analysis of yeast genomic DNA
with a probe consisting of a 2.3-kb ClaI-BstEII DNA fragment
internal to the CDC53 coding region (see below) did not indi-
cate the presence of any cross-hybridizing DNA within the
yeast genome (29). These results indicate that we have cloned
the wild-type allele of CDC53 and that there are no other
genes closely related to CDC53 within the yeast genome.
We next determined whether the phenotype of cells contain-
ing a completely nonfunctional CDC53 gene was similar to the
arrest phenotype of the cdc53 temperature-sensitive mutants.
Null alleles of CDC53 were created by transforming diploid
strains MGG3 and MGG48 with EcoRI-digested pGEM53-
DBglII::HIS3 (see Materials and Methods). This results in the
replacement of 1.6-kb of the CDC53 coding region (see below)
by HIS3. After verifying by Southern analysis that one trans-
formant from each strain contained the expected replacement,
these strains were sporulated and subjected to tetrad analysis.
In a total of 27 tetrads, only two viable spores (none of which
was His1) were recovered from each tetrad, indicating that
CDC53 is an essential gene. Microscopic examination revealed
that most of the inviable spores had progressed through several
rounds of cell division to form a microcolony before arresting.
Each cell in these microcolonies had developed multiple, elon-
gated buds that were indistinguishable from the aberrant buds
seen after the cell cycle arrest of cdc53 temperature-sensitive
mutants. Thus, the phenotype of the cdc53 temperature-sensi-
tive mutations suggests that these alleles suffer a loss-of-func-
tion defect upon transfer to the restrictive temperature.
The DNA sequence was determined for the complementing
3.6-kb EcoRI fragment, revealing an open reading frame
(ORF) for a protein of 815 amino acids with a calculated
molecular mass of 94 kDa (Fig. 2). The most striking feature of
the predicted protein is its basic nature (predicted pI 5 8.7).
Comparison of the protein sequence with those in GenBank
with BLAST (2) identified two proteins encoded by Caeno-
rhabditis elegans genes that are related to Cdc53p, the cul-1
product (23; accession number Z35639) and the cul-4 product
(23; accession number U29536). Other sequences similar to
the derived Cdc53p sequence are an ORF identified on chro-
mosome I of Schizosaccharomyces pombe (accession number
Z54142) and a mammalian protein thought to be involved in
vasopressin-dependent calcium mobilization, VACM-1 (4; ac-
cession number S78157). Figure 3 shows an alignment of the
products of CDC53 and cul-1 with the Cdc53p-like protein of
S. pombe and the VACM-1 protein. Although Cdc53p shows
only about 25% identity to each of these proteins, all four
proteins are identical at over 50 positions, which are clustered.
A similarity search of the EST sequence library also indicates
that at least four additional distinct mammalian proteins are
members of this family (23). Thus, the Cdc53/CUL-1 protein
family is widely conserved.
A TBLAST search of the predicted sequence of Cdc53p
against the Saccharomyces Genome Database (Stanford Uni-
versity) also revealed that there are two other ORFs in the
yeast genome with similarity to Cdc53p, Ygr003p and Yj1047p
(Fig. 4). Again the sequences are not closely related overall,
TABLE 2. Synthetic lethality of cdc4, cdc34, and cdc53 mutant combinations
Cross
Mutation in cross Spore recovery (live/total)
a b wild type a b a,b
SJ1026-1B 3 MGG15 cdc4-3 cdc34-2 17/17 18/19 19/19 0/17
SJ1026-7B 3 SJ1080-8C cdc4-3 cdc53-1 25/25 25/27 24/27 0/25
SJ1012-4 3 SJ1080-6C cdc4-5 cdc53-1 27/27 22/27 27/27 0/27
MGG11 3 MGG10 cdc34-2 cdc53-1 13/13 23/25 22/25 0/12
H3C1B5 3 SJ1078-2B cdc3-1 cdc4-3 16/17 7/10 10/11 11/16
H3C1B5 3 SJ1098-3D cdc3-1 cdc34-2 9/10 15/16 16/16 10/10
H122-12-3 3 SJ1078-2B cdc10-1 cdc4-3 9/9 18/19 19/19 9/9
H122-12-3 3 SJ1078-3D cdc10-1 cdc34-2 8/8 18/18 18/18 8/8
6353-14-3 3 7414-2-3 cdc4-1 cdc28-1 27/29 27/29 26/29 27/29
6353-4-1 3 5579-5-2 cdc4-1 cdc36-16 9/9 21/21 21/21 9/9
MGG12 3 H2C2A-1 cdc53-1 cdc2-2 15/15 125/125 125/125 15/15
SJ1078-2B 3 5566-1-1 cdc4-3 cdc39-1 14/16 4/5 4/5 16/16
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the regions of similarity are clustered and are predominantly
located within the COOH termini of the gene products. Dis-
ruption of either of these ORFs does not lead to inviability,
indicating that Cdc53p is the only essential member of this
family in S. cerevisiae (29).
Suppression of mutations in CDC4 and CDC34 by overex-
pression of CDC53. Because our analysis for synthetic lethal-
ity had suggested that CDC4, CDC34, and CDC53 might co-
operate in conferring a common function, we used the cloned
genes to seek additional evidence for relevant interactions.
The three wild-type genes, including their putative promoter
regions, were placed under the control of a yeast GAL pro-
moter in high-copy-number (2mm-based) plasmids (see Mate-
rials and Methods). These plasmids were then individually
transformed into strains carrying a cdc4-3, cdc4-5, cdc34-2, or
cdc53-1 mutant allele. When the transformants were trans-
ferred to 348C, overexpression of CDC53 was seen to suppress
the lethality caused by either cdc4-5 (with or without galac-
tose induction) or by cdc34-2 (with galactose induction) (Table
3). In contrast, overexpression of CDC34 on galactose sup-
pressed cdc53-1 but failed to suppress either cdc4 allele. In
fact, overexpression of CDC34 caused cdc4 mutants to be-
come inviable under normally permissive conditions (238C).
Modest overexpression of CDC4 suppressed the cdc53-1 mu-
tation at 348C, but higher-level (galactose-induced) expres-
sion of CDC4 caused cells mutant for either cdc34-2 or cdc53-1
to become inviable at 238C (Table 3). Interestingly, while
overexpression of CDC53 could suppress the temperature sen-
sitivity of the cdc4-5 strain, it did not suppress the cdc4-3 al-
lele (Table 3) or several other cdc4 alleles (cdc4-1, -2, -4, -6,
and -7) that were tested (22). The positions of these latter
mutations in CDC4 have been mapped to the region encod-
FIG. 2. DNA sequence of CDC53 and the predicted amino acid sequence of its gene product.
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ing the WD-40 repeats of Cdc4p, whereas the cdc4-5 allele
maps to a nonrepetitive amino-terminal portion of Cdc4p that
is essential for function (22). These results suggest that Cdc53p
interacts with this amino-terminal portion of Cdc4p rather
than with the WD-40 repeats. Taken together, the suppression
data provide additional strong genetic evidence that the en-
coded proteins interact.
Characterization of Cdc53p. To allow assays of Cdc53p,
rabbit antibodies were generated against a TrpE-Cdc53p fu-
sion (see Materials and Methods). In yeast extracts, these
antibodies recognized protein species of 92 and 98 kDa (Fig. 5,
lane 1), similar to the predicted mass (94 kDa) of Cdc53p.
Several results indicate that these antibodies recognize Cdc53p
and that both the 92- and 98-kDa proteins are products of
CDC53. First, an extract from cells overexpressing wild-type
CDC53 has elevated levels of both the 92- and 98-kDa proteins
(Fig. 5, lanes 4 and 5), whereas extracts from cells containing
cdc53-1 have decreased levels of the 92-kDa protein (Fig. 5,
lane 6). Second, an extract from cells expressing a nonfunc-
tional form of Cdc53p that contains an internal deletion of
amino acid residues 582 to 665 (expressed from pCDC53-
20) contains an 80-kDa protein that is recognized by the anti-
bodies (Fig. 5, lane 2). Expression of CDC53*, encoding a
protein in which the carboxyl-terminal 23 amino acids are
replaced by vector-encoded sequence (expressed from either
pFUS53-3 or pYcDE-53; Fig. 2 and Materials and Meth-
ods) contained an increased level of a 98-kDa fusion protein
that is consistently greater than the level of Cdc53p achieved
by overexpressing wild-type CDC53 (Fig. 5, lane 3). Interest-
ingly, the 98-kDa Cdc53p has recently been shown to be ubiq-
uitinated (48). However, overproduction of the CDC53*-en-
coded fusion protein does not lead to the appearance of a
higher-molecular-mass form equivalent to the 98-kDa protein
seen with overexpression of wild-type CDC53, suggesting that
the increased levels of this protein might be due to removal of
signals required for its ubiquitination and targeted degrada-
tion.
Copurification of Cdc4, Cdc34, and Cdc53. We next sought
direct evidence that the three proteins Cdc4p, Cdc34p, and
Cdc53p interact. We constructed plasmid YEpGALHis34,
which encodes a 6-His-tagged Cdc34p (see Materials and
Methods) that can rescue cells containing a cdc34 null muta-
tion. YL10-1 cells containing YEpGALHis34 were grown at
368C on either galactose- or glucose-containing medium; ly-
sates were prepared as described in Materials and Meth-
ods, and the His-tagged Cdc34p was purified by nickel affinity
chromatography. Lysate and Ni21-nitrilotriacetic acid agarose
(with protein bound to the nickel beads) were subjected to
SDS-polyacrylamide gel electrophoresis, and Western blot
analysis was performed with anti-Cdc4, anti-Cdc34, and anti-
Cdc53 antibodies. Samples were treated such that quantitative
binding of a protein to the nickel beads should result in a
20-fold enrichment of the protein relative to the abundance
of the protein in the initial lysates. As can be seen in Fig. 6,
His-tagged Cdc34p is highly enriched after nickel affinity chro-
matography, and no cross-reacting signal can be detected in
lysates lacking the His-tagged Cdc34p. Comparison of expo-
sure intensities indicates that about 80% of the His-tagged
Cdc34p is recovered from the nickel beads. While Cdc4p is
undetectable in lysates, it copurifies with His-tagged Cdc34p
and can be easily detected in the protein bound to the nickel
beads (Fig. 6). About 25% of the 92-kDa species of Cdc53p
is also found bound to the nickel beads, but only in the pres-
ence of the His-tagged Cdc34p (Fig. 6). Thus, even in the
presence of native Cdc34p, substantial fractions of cellular
Cdc4p and Cdc53p are bound to the nickel beads by binding
to the His-tagged Cdc34p (Fig. 6). Although the 98-kDa spe-
cies of Cdc53p can be detected in the absence of His-tagged
Cdc34p, it is also highly enriched in the presence of the His-
tagged Cdc34p protein. These interactions are specific, as a
number of cross-reacting bands seen with the anti-Cdc4
and anti-Cdc34 antibodies are eliminated by this purification
procedure. Together, these data suggest that Cdc4p, Cdc34p,
and Cdc53p are associated in a multiprotein complex.
FIG. 2—Continued.
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DISCUSSION
In S. cerevisiae, CDC4 and CDC34 are required for the
transition from late G1 to S phase (for a review, see reference
33). Cells mutant for CDC4 or CDC34 can undergo the Start-
dependent events of SPB duplication, bud emergence, and
activation of MBF- and SBF-dependent transcription (5, 6, 14,
24). However, these mutants fail nuclear DNA replication,
spindle formation, and cytokinesis. We have identified several
alleles of the novel essential gene CDC53 that cause identical
phenotypic traits, suggesting that CDC53 is required for the
same cell cycle function as CDC4 and CDC34. Further evi-
dence for a functional relationship among these three genes is
provided by striking genetic interactions among the mutant
alleles. First, cdc53-1 is synthetically lethal with cdc4-3, cdc4-5,
and cdc34-2 at 238C. This synthetic lethal effect apparently
results from a loss of function that is very similar to that caused
by temperature sensitivity for any one of the three genes,
because cells suffering this synthetic lethality arrest develop-
ment with the same terminal morphology as that of the indi-
vidual mutants. Second, overexpression of CDC53 suppresses
the cdc34-2 and cdc4-5 temperature-sensitive alleles, and over-
expression of CDC34 suppresses cdc53-1. Depending on the
level of overexpression achieved, CDC4 can either suppress
cdc53-1 (multiple copies expressed from the CDC4 promoter)
or enhance the cdc53-1 phenotype (multiple copies expressed
from the GAL10 promoter).
Together, these results suggest that the Cdc53p protein in-
teracts with Cdc4p and Cdc34p in a common function that
mediates the transition from late G1 into S phase. Decreases in
this function resulting from combining mild mutations for any
FIG. 3. Comparison of the Cdc53p-related proteins from C. elegans, S. pombe, and rabbits. Protein sequences were aligned by using the multiple sequence alignment
program MACAW (40) and the SeqVu software program (Garvan Institute of Medical Research). Positions where Cdc53p is identical to at least two of the other three
proteins are boxed.
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FIG. 4. Comparison of Cdc53p with Ygr003p and Yjl047p. Protein sequences were aligned as described in the legend to Fig. 3. Positions where two of the three
proteins are identical are boxed.
TABLE 3. Effects of overexpressing CDC4, CDC34, and CDC53 in cdc4, cdc34, and cdc53 mutantsa
Mutationb
Vectorc CDC4 CDC34 CDC53
Raffinose Galactose Raffinose Galactose Raffinose Galactose Raffinose Galactose
None 1 1 1 1 1 1 1 1
cdc4-3 2 2 1 1 2 2d 2 2
cdc4-5 2 2 1 1 2 2d 1 1
cdc34-2 2 2 2 2d 1 1 2 1
cdc53-1 2 2 1 2d 2 1 1 1
a Growth monitored at 348C unless otherwise indicated.
b Strains: wild-type, Ts1 revertant of SJ1026-7B; cdc4-3, SJ1026-7B; cdc4-5, SJ1012-4; cdc34-2, SJ1098-3D; cdc53-1, SJ1080-4D.
c Plasmids: vector, pSJ101; CDC4, pSJ4101; CDC34, pFUS34; CDC53, pFUS53-3.
d Growth monitored at 238C.
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two members of the set to generate synthetic lethality or from
a stronger mutation affecting any one member yield the same
terminal phenotype. The interaction between CDC53 and
CDC4 is particularly intriguing. The cdc4-5 allele that can be
suppressed by overexpressing CDC53 is located within a region
of CDC4 encoding an essential domain of Cdc4; in contrast,
CDC53 does not suppress a number of alleles that have been
mapped to the portion of CDC4 encoding WD-40 repeats.
These data suggest that Cdc53p binding to Cdc4p is weakened
in the protein encoded by cdc4-5 and that overproduction of
Cdc53p enhances its interaction with this essential domain of
Cdc4p. Finally, direct evidence that the three proteins reside in
a single complex comes from the copurification of Cdc4p and
Cdc53p with His-tagged Cdc34p by nickel chromatography.
Together, these data demonstrate that these three proteins
interact strongly with one another.
The present evidence clearly indicates that Cdc53p functions
in conjunction with Cdc34p, which is a ubiquitin-conjugating
enzyme (12). Ubiquitin is a small, highly conserved protein
that is found as a posttranslational modification of substrate
proteins (for a review, see reference 19). Ubiquitin is activated
in an ATP-dependent manner by a ubiquitin-activating or E1
enzyme, which forms a thioester linkage between the COOH-
terminal glycine of ubiquitin and a cysteine within the E1
enzyme. The E1 enzyme then transfers the ubiquitin to any one
of a family of proteins known as ubiquitin-conjugating en-
zymes, again via a thiolester linkage. Finally, often in a manner
dependent on another activity known as an E3 enzyme or
ubiquitin ligase, ubiquitin is attached to a substrate protein via
an isopeptide linkage, thereby targeting the substrate for pro-
teolysis by the proteasome.
Although the exact function of Cdc53p remains to be estab-
lished, it is likely that this protein is involved in controlling the
ubiquitin-dependent degradation of cell cycle mediators in
concert with Cdc34p. The known substrates of Cdc34p include
both the G1 cyclins (8, 47, 48) and the cyclin-dependent kinase
inhibitors Far1p and Sic1p (30, 41). One possibility is that
Cdc53p controls the level of activity of the Cdc34p. Alterna-
tively, Cdc53p may be necessary to bring Cdc34p in proximity
to its substrates. A third possibility is that Cdc53p functions as
an E3 protein. Recently, Scheffner et al. (39) demonstrated
that members of at least one family of E3 proteins directly
form a thiolester linkage with ubiquitin and presumably go on
to form an isopeptide linkage between ubiquitin and the sub-
strate protein. While a mechanism of this type may be unlikely
in the case of Cdc53p-like proteins (members of this family do
not contain the conserved cysteine [Fig. 3] that serves as the
ubiquitin acceptor in the recently described family of E3 pro-
teins [18]), it cannot be ruled out at this time.
Sequence comparison shows that Cdc53p is a member of a
family of proteins present in a diversity of organisms, including
S. pombe, C. elegans, and humans. Not only are these related
proteins present in these various organisms, but multiple ho-
mologs are known to exist in both C. elegans and humans.
Although the functions of these proteins are unknown, their
amino acid sequence similarity to Cdc53p suggests that they
might also serve to regulate protein degradation events, pos-
sibly by controlling the activity of other ubiquitin-conjugating
enzymes. Although the cellular multiplicity of Cdc53p-like pro-
teins may indicate a diversity of functions for such proteins, at
least some members of this family share with Cdc53p a critical
role in cell cycle control events in other organisms as well. The
cul-1 gene of C. elegans encodes a Cdc53p-like protein (23).
Mutations in cul-1 cause a defect in the ability of cells to arrest
cell division during development. Thus, CUL-1 acts as an in-
hibitor of entry into the cell division cycle. Although this in-
hibitory role appears to be dissimilar to the stimulatory func-
tion of Cdc53p, we speculate that Cdc53p-like proteins may
share a common role in controlling the abundance of cell cycle
regulatory molecules that may either promote or oppose cell
cycle progression in different organisms. Thus, Cdc53p and
CUL-1 define a novel set of proteins and suggest a potential
role for this large conserved protein family in controlling cell
division events as regulators of ubiquitin-dependent protein
degradation.
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FIG. 5. Western blot analysis of Cdc53p. Cells were grown at 238C. Protein
was extracted and subjected to Western analysis with anti-Cdc53 antibodies.
Lanes: 1, Y382; 2, Y382(pCDC53-20); 3, Y382(pYcDE-53); 4, Y382(pCDC53-
11); 5, Y382(pNM53); 6, MGG12 (cdc53-1). Arrows indicate positions of a
cross-reacting protein that served as the loading control. Approximately equal
amounts of protein were loaded into each lane as also determined by Coomassie
blue staining of identical samples.
FIG. 6. Copurification of Cdc4p, Cdc34p, and Cdc53p. Nickel chromatog-
raphy was used to purify His-tagged Cdc34p from strain YL10-1 harboring
YEpGALHis34. Mock purification was performed with strain Y382 lacking His-
tagged Cdc34p. Western analysis was performed on material bound to the beads
as well as the original lysate, using an anti-Cdc4, anti-Cdc34, or anti-Cdc53
antibody.
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